(NYSE: CBT) Cabot's forecast annual revenue growth rate of 1.46% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.
Cabot's revenue in 2025 is $3,713,000,000.On average, 6 Wall Street analysts forecast CBT's revenue for 2026 to be $191,705,164,224, with the lowest CBT revenue forecast at $180,966,712,696, and the highest CBT revenue forecast at $204,030,579,032. On average, 6 Wall Street analysts forecast CBT's revenue for 2027 to be $197,153,738,152, with the lowest CBT revenue forecast at $186,626,881,728, and the highest CBT revenue forecast at $209,003,063,976.
In 2028, CBT is forecast to generate $205,882,036,192 in revenue, with the lowest revenue forecast at $197,788,523,464 and the highest revenue forecast at $217,837,159,568.